Researchers have discovered that alternative promoter usage in triple-negative breast cancer drives tumor heterogeneity and patient outcomes. The HDAC9 gene shows dramatic promoter switching that correlates with survival differences, opening new diagnostic possibilities.
Scientists have discovered that maternal factor OTX2 orchestrates the critical transition when human embryos take control of their own development. This breakthrough reveals fundamental differences between human and mouse embryonic development with significant clinical implications.
Breakthrough Discovery in Mosquito Saliva Research Scientists have uncovered a surprising therapeutic potential within an unlikely source: mosquito saliva. Recent…
